Position in SEPN
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$413,316
+$6,268 QoQ
Shares Held
17,200
+17.8% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SEPN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STRS OHIO holds $144,231,722 across 124 Biotechnology names. SEPN ranks #57 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
74,163 | $33,116,746 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
31,656 | $24,458,691 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
35,532 | $11,756,472 | |
| 4 | INSM |
INSMED Inc
|
52,009 | $8,504,511 | |
| 5 | MRNA |
Moderna, Inc.
|
77,471 | $3,935,526 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
28,914 | $2,514,650 | |
| 7 | EXEL |
Exelixis, Inc.
|
51,303 | $2,200,385 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
28,782 | $2,161,240 |
All Filings in SEPN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $413,316 | 17,200 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $407,048 | 14,600 | Shares | Sole | 2026-02-02 | |
| 2025-06-30 | $35,938 | 3,400 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $19,686 | 3,400 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $77,860 | 3,400 | Shares | Sole | 2025-05-28 | |
| No filing history on record for this holder in this stock. | ||||||